ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
January 27, 2021Samsung Biologics announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO service provider in the ... -
GenScript ProBio, Eutilex Enter Cancer Collaboration
April 10, 2020Partner on plasmid and virus process development and manufacturing for CAR-T programs. -
GenScript ProBio and Eutilex Enter into Exclusive Strategic Collaboration on Plasmid and Virus Process Development and Manufacturing for CAR-T Programs
April 07, 2020GenScript Biotech Corporation's CDMO business GenScript ProBio (hereinafter referred to as GenScript ProBio) and Eutilex Co., Ltd. (hereinafter referred to as Eutilex) committed to developing anti-cancer immunotherapy technology jointly announced that the -
Samsung Biologics Signs CDO Deal with Eutilex
March 21, 2019Samsung Biologics signed on March 20 a contract development organization (CDO) agreement with Eutilex for developing cancer immunotherapy medicine.
Pharma Sources Insight January 2025
